FindTrial
Sign In

Studying How the AIWeLL DM Program Helps People Manage Diabetes Better

To Evaluate the Effectiveness of a Whole-System Medicine Approach-Based AIWeLL DM Protocol on Diabetes: A Single-Arm Pre-Post Study - AIWeLL-DM

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084421
Enrollment
129
Registered
2025-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

AYUR.AI PRIVATE LIMITED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes patients, prediabetes 2. Duration of Diabetes should be less than 10 years

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes patients 2. Gestational diabetes 3. Smokers and alcoholics 4. T2DM patients under insulin 5. Pregnancy and Lactation 6. Diabetes patients with co-morbidities

Design outcomes

Primary

MeasureTime frame
Complete Blood Count (CBC), Urine Routine Examination, Diabetic Profile, Lipid Profile, Liver Profile, Kidney ProfileTimepoint: Before treatment, after treatment—

Secondary

MeasureTime frame
CGM indices, Gut microbiome composition (16sRNA metagenomic sequencing)Timepoint: Before treatment, after treatment—

Countries

India

Contacts

Public ContactDr Gangadevi BAMS

Sri Sarada Ayurveda Clinic

dr.gangadevi95@gmail.com9361052618

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026